Gallagher Neil reported FHTX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001972849-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 24, 2026

Published

Jun 25, 2026

Ingested by INSIDER

Nov 5, 03:51 UTC

Last re-read

Nov 5, 03:51 UTC

Extracted facts

Filer

Gallagher Neil

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Foghorn Therapeutics Inc. — Stock Options (Right to buy)

Ticker

FHTX

Shares

28.0K

Price per share

$4.08

Value

$114,240

Execution date (reported)

Jun 24, 2026

Owned after transaction

28.0K shares

Days from execution to publication

1

Calculation

What this establishes

Gallagher Neil filed this Form 4 reporting a grant or award of FHTX on Jun 24, 2026. It became public on Jun 25, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Gallagher Neilcik:0001972849

Issuer

Foghorn Therapeutics Inc.cik:0001822462

Revision history · 0

No field has changed since this record was first ingested.